n-methylacrylamide has been researched along with Pyrrolidine-1-carbonitrile in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramite, JA; Anderson, DP; Aulabaugh, A; Brown, MF; Che, Y; Chen, JM; Dahal, UP; Flanagan, ME; Gilbert, AM; Hayward, MM; Li, C; Montgomery, J; Noe, MC; Obach, RS; Oppenheimer, SR; Philippe, L; Ryder, T; Schuff, BP; Shanmugasundaram, V; Shapiro, MJ; Starr, J; Stroh, J; Uccello, DP; Walker, GS; Wu, Y | 1 |
| Gehringer, M; Laufer, SA | 1 |
1 review(s) available for n-methylacrylamide and Pyrrolidine-1-carbonitrile
| Article | Year |
|---|---|
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
Topics: Conserved Sequence; Drug Discovery; Humans; Molecular Targeted Therapy | 2019 |
1 other study(ies) available for n-methylacrylamide and Pyrrolidine-1-carbonitrile
| Article | Year |
|---|---|
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.
Topics: Drug Design; Enzyme Inhibitors; Glutathione; Humans; Kinetics; Mass Spectrometry; Nuclear Magnetic Resonance, Biomolecular; Pharmaceutical Preparations | 2014 |